Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
miR-17-HG deletion + MYC positive
Cancer:
Lymphoma
Drug:
phenformin
(
mTOR inhibitor
,
AMPK activator
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Cell Reports Medicine
Title:
Repression of LKB1 by miR-17~92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
Published date:
05/19/2020
Excerpt:
Em-Myc lymphoma cells deleted for miR-17 92 (D/D) were more resistant to phenformin treatment…
DOI:
https://doi.org/10.1016/j.xcrm.2020.100014
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login